The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Real-world data on outcomes using taxane, trastuzumab, and pertuzumab (THP) in patients with early stage HER2+ breast cancer.
 
Harsh Sharma
No Relationships to Disclose
 
Jordyn Kreutzfeldt
No Relationships to Disclose
 
Tej Mehta
No Relationships to Disclose
 
Kiah Farr
No Relationships to Disclose
 
Ursa Brown-Glaberman
Consulting or Advisory Role - Biotheranostics; Macrogenics; Novartis; Sanofi/Aventis; Seagen; Taiho Oncology
Research Funding - Seagen (Inst)
 
Pavani Chalasani
Consulting or Advisory Role - Amgen; Asthenext; AstraZeneca; Atossa Genetics; Bayer; bioTheranostics; Eisai; HERON; Lilly; NanoString Technologies; OncoSec; Puma Biotechnology
Research Funding - Amgen; BioAtla; Carrick Therapeutics; Genentech/Roche; Lilly; Pfizer; Phoenix Molecular Designs; Radius Health; Ventana Medical Systems; Zentalis
Patents, Royalties, Other Intellectual Property - Provisional patent submitted for using Syndros for management of pain from bone metastases (Inst)
 
Jacklyn Nemunaitis
No Relationships to Disclose
 
Jennifer Margaret Segar
No Relationships to Disclose